Director, Payer Strategy Development (Remote) #2436

Job Description

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC is a wholly-owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit www.grail.com . Working in collaboration with the Government Affairs and Commercial Payer teams, the Director will play an integral role in leading the overall strategy and engagement with public payers and driving policy and reimbursement goals related to value and evidence for coverage of GRAIL products.

You will:

• Be responsible for working across GRAIL to drive policy and reimbursement goals, including public payer engagement, evidence development for coverage, and development of innovative coverage pathways with public and private payers.
• Develop and implement a strategic plan for key public payers with specific measurable objectives that support the business plan for each payer type.
• Translate reimbursement strategy into national and applicable state level policy strategy. Articulate, advance, and implement a strategic and tactical approach in support of the coverage priorities.
• Support the development and implementation of a strategy for review and inclusion in guidelines (e.g., USPSTF, NCCN, ACS, etc.)
• Develop strong working relationships with key internal stakeholders to drive an evidence generation strategy in support of coverage and reimbursement of current and future screening and diagnostic products including HEOR, medical affairs, regulatory affairs, marketing, and commercial colleagues.
• Direct cross functional work on the development of innovative coverage arrangements and pathways with public and private payers in support of long-term reimbursement and coverage.
• This role can be remote.

Your background should include:

• A Bachelor’s Degree or equivalent.
• A minimum of fourteen (14) years of experience with public payers and reimbursement policy at the national or state level.
• Successful track record of being a leader in managing complex policy issues and/or reimbursement strategic plans at a company, trade association, or relevant Department or Agency.
• Understanding of the molecular diagnostic and screening testing market, including products, companies, and technology.
• Ability to develop and maintain strong internal and external relationships while enhancing the company’s policy positions in support of coverage.
• Understanding of coverage in public programs, including Medicare and Medicaid.
• Superior interpersonal communication (written and verbal), and organizational skills
• Innovative, energetic, entrepreneurial and resourceful; diplomatic, intuitive, inquisitive and mature; willing to offer opinions, suggestions, and judgments that are supported by sound logic.

Preferred Education and Experience:

• An advanced degree.
• Experience working with health outcomes research studies.

GRAIL is an Equal Employment Office and Affirmative Action Employer and does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other legally protected status. We will reasonably accommodate all individuals with disabilities so that they can participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation. Following extensive monitoring, consideration of business implications, and advice from internal and external experts, GRAIL US has made the decision to require that all U.S. employees be “Fully Vaccinated” with the COVID-19 vaccine and “Up to Date” with any recommended booster. “Fully Vaccinated” is defined as two weeks after both doses of a two-dose vaccine (e.g. Pfizer or Moderna) or two weeks since a single-dose vaccine (e.g. Johnson & Johnson) has been administered; "Up to Date" means having timely received any COVID-19 vaccine booster(s) in accordance with CDC guidelines. Absent a qualifying exemption, all GRAIL US employees are to comply with this requirement, including providing documentation of such vaccination status, as a condition of employment. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation for consideration by GRAIL. Apply for this job